What the public record says
The TGA says the Personal Importation Scheme can allow individuals to import therapeutic goods not entered in the ARTG only if all conditions are met. Those conditions include personal or immediate-family use, no supply to anyone else, a valid Australian prescription or written authority for prescription-only medicines, no more than a 3-month supply in a single order, no more than a 15-month supply in 12 months, no controlled substances, and clear labels. Counterfeit products are prohibited under any circumstances.
What buyers should check
- Do not treat the phrase personal importation as legal advice from a seller.
- If the medicine is prescription-only in Australia, the TGA says the importer must hold a valid Australian prescription or written authority at the time of importation.
- The TGA says one import cannot exceed a 3-month supply at the maximum prescribed dose for prescription-only medicines or manufacturer-recommended dose for non-prescription goods.
- The TGA says total quantity imported within any 12-month period must not exceed a 15-month supply.
- The TGA says products must be for the individual or immediate family member only and cannot be sold, supplied, or given away.
- The TGA warns counterfeit products are prohibited from importation even if the buyer has a prescription.
- The TGA says unclear, mismatched, or missing labels can stop products being released because identity cannot be confirmed.
- Peptide Checker did not find a primary TGA source for the claimed February 2026 formal-declaration rule in this pass, so that claim is not published as fact.
Source links
- TGA Personal Importation Scheme
- TGA unapproved peptide products safety advisory
- TGA importing medicine or medical device
Use this regulatory brief to ask better supplier questions. Do not convert a market-level warning into a vendor-specific claim unless the vendor page has a source attached.
Open vendor scorecards